Acadia Pharma GAAP EPS of $0.86 beats by $0.63, revenue of $259.6M misses by $13.44M

by
Contributor since / Followers

2 months ago

Acadia Pharma press release (NASDAQ:ACAD): Q4 GAAP EPS of $0.86 beats by $0.63.
Revenue of $259.6M (+12.4% Y/Y) misses by $13.44M.
Shares +0.11%.
2024 total net product sales of $957.8 million, reflecting 32% revenue growth

– Fourth quarter DAYBUE^®

Tags: ACAD